TrialCritical care (London, England)2023

Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trial.

Leila N Atmowihardjo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.